August 26, 2025

Defining optimal strategies for skull base reconstruction

Edward Kuan, MD leads a 68-expert team to define best practices for skull base reconstruction in a landmark international study.

UCI Health

June 13, 2025

FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) ?1] as determined by an FDA-approved test.

Dana-Farber

March 26, 2019

Complex Mandibular Reconstruction: A Sentara Specialty

Mandibular reconstruction restores both mandible structure and function after the removal of cancerous bone. Surgeons use a fibula free flap, harvested from the patient’s own leg, to create replacement tissue for the new mandible.

Sentara

August 04, 2023

Join Mount Sinai for the Seventh Annual Endoscopic Middle Ear Surgery Dissection CME Course

Course material and hands-on laboratory dissection will be appropriate for both novice and advanced endoscopic ear surgeons. For those unable to travel to New York City, this course also contains a virtual lecture component.

Mount Sinai New York

November 01, 2022

A Radical Shift in the Communication Paradigm in Head and Neck Frozen Section Analysis: Intraoperative Three-Dimensional Specimen Scanning

We describe a new method of intraoperative communication of margin mapping results for head and neck cancer specimens.

Mount Sinai New York

July 26, 2021

Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021

With the international community of experts in head-and-neck cancers gathering virtually to share new ideas and treatment strategies at the American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer, underway now, Roswell Park Comprehensive Cancer Center teams are presenting new research on both the basic science supporting new treatments as well as opportunities to improve the early and accurate diagnosis of thyroid cancer and other head/neck malignancies.

Roswell Park Comprehensive Cancer Center

April 27, 2025

Immunotherapy Before and After Surgery Improves Outcomes in Head and Neck Cancer

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim analysis of a randomized, open-label phase 3 clinical trial led by investigators from Dana-Farber Brigham Cancer Center and Washington University School of Medicine in St. Louis.

Dana-Farber

March 15, 2022

Researchers Identify Guidelines to Decrease Post-Intubation Complications

Physicians have long known that intubations come with their share of complications. Researchers within the Department of Otolaryngology-Head and Neck Surgery at the Icahn School of Medicine at Mount Sinai want to help change that by developing concrete, evidence-based intubation protocols that standardize the use of endotracheal tubes across medicine.

Mount Sinai New York

June 10, 2024

Dysphagia

Dr. Matthew Rohlfing, MD shares an overview of swallowing and how to evaluate dysfunctions of swallowing.

Barnes-Jewish